NanoString Technologies (NSTG) Director William Young Acquires 30,000 Shares

NanoString Technologies (NASDAQ:NSTG) Director William Young acquired 30,000 shares of the business’s stock in a transaction on Tuesday, March 13th. The stock was bought at an average cost of $6.91 per share, for a total transaction of $207,300.00. Following the completion of the transaction, the director now directly owns 30,000 shares of the company’s stock, valued at $207,300. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.

NASDAQ:NSTG traded down $0.12 during midday trading on Friday, hitting $7.75. 105,823 shares of the stock were exchanged, compared to its average volume of 336,065. NanoString Technologies has a one year low of $5.87 and a one year high of $20.16. The stock has a market cap of $197.16, a price-to-earnings ratio of -4.21 and a beta of 0.75. The company has a debt-to-equity ratio of 1.22, a current ratio of 3.40 and a quick ratio of 2.84.

How to Become a New Pot Stock Millionaire

NanoString Technologies (NASDAQ:NSTG) last announced its earnings results on Wednesday, March 7th. The biotechnology company reported ($0.34) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.42) by $0.08. The firm had revenue of $35.20 million for the quarter, compared to analysts’ expectations of $31.57 million. NanoString Technologies had a negative return on equity of 129.90% and a negative net margin of 37.91%. The firm’s quarterly revenue was up 39.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.55) earnings per share. sell-side analysts expect that NanoString Technologies will post -2.79 EPS for the current year.

A number of institutional investors have recently bought and sold shares of NSTG. Two Sigma Investments LP grew its position in NanoString Technologies by 384.8% during the 4th quarter. Two Sigma Investments LP now owns 76,332 shares of the biotechnology company’s stock worth $570,000 after purchasing an additional 60,587 shares in the last quarter. Deutsche Bank AG grew its holdings in shares of NanoString Technologies by 96.2% during the 4th quarter. Deutsche Bank AG now owns 97,823 shares of the biotechnology company’s stock valued at $730,000 after acquiring an additional 47,968 shares in the last quarter. Broadfin Capital LLC purchased a new position in shares of NanoString Technologies during the 4th quarter valued at $747,000. Geode Capital Management LLC grew its holdings in shares of NanoString Technologies by 17.0% during the 4th quarter. Geode Capital Management LLC now owns 176,701 shares of the biotechnology company’s stock valued at $1,319,000 after acquiring an additional 25,632 shares in the last quarter. Finally, Altrinsic Global Advisors LLC grew its holdings in shares of NanoString Technologies by 54.3% during the 4th quarter. Altrinsic Global Advisors LLC now owns 483,111 shares of the biotechnology company’s stock valued at $3,609,000 after acquiring an additional 170,000 shares in the last quarter. Hedge funds and other institutional investors own 91.96% of the company’s stock.

A number of equities analysts recently commented on NSTG shares. Zacks Investment Research upgraded NanoString Technologies from a “hold” rating to a “buy” rating and set a $8.25 price target for the company in a research note on Wednesday, January 3rd. ValuEngine downgraded NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, February 2nd. Finally, Morgan Stanley restated an “equal weight” rating and issued a $12.00 target price (down from $13.00) on shares of NanoString Technologies in a research note on Thursday, March 8th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $13.06.

ILLEGAL ACTIVITY WARNING: “NanoString Technologies (NSTG) Director William Young Acquires 30,000 Shares” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/nanostring-technologies-inc-nstg-director-buys-207300-00-in-stock.html.

About NanoString Technologies

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply